🇺🇸 FDA
Patent

US 8269014

Thiophene analogues for the treatment or prevention of flavivirus infections

granted A61KA61K38/005A61K38/21

Quick answer

US patent 8269014 (Thiophene analogues for the treatment or prevention of flavivirus infections) held by Vertex Pharmaceuticals (Canada) Incorporated expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals (Canada) Incorporated
Grant date
Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/005, A61K38/21, A61P, A61P1/16